Health Care: Drugs

Idexx Laboratories (IDXX: NASDAQ)

$148.24 n/a | n/a%
12/19/14 - 03:59 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 1.38B 1.29B 1.22B 1.10B
Cost of Sales 566.34M 541.78M 523.98M 478.81M
Gross Operating Profit 810.71M 751.56M 694.71M 624.58M
Selling, General, and Administrative Expenses 401.35M 354.57M 334.24M 306.14M
Research & Development 88.00M 82.01M 76.04M 68.60M
Operating Income before D & A (EBITDA) 321.36M 314.97M 284.43M 249.84M
Depreciation & Amortization 54.60M 52.41M 48.20M 45.96M
Interest Income 1.88M 1.90M 1.74M 663.00K
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 268.65M 264.46M 237.97M 204.54M
Interest Expense 5.39M 3.85M 3.55M 2.42M
Pre-Tax Income 263.26M 260.62M 234.42M 202.13M
Income Taxes 75.47M 82.33M 72.67M 60.81M
Minority Interest -6.00K 20.00K -32.00K 36.00K
Net Income From Continuing Operations 187.79M 178.29M 161.75M 141.32M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 187.79M 178.29M 161.75M 141.32M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 187.80M 178.27M 161.79M 141.28M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
187.79M 178.29M 161.75M 141.32M
Preferred Dividends
Net Income Available To Common 187.79M 178.29M 161.75M 141.32M
Basic EPS from Continuing Ops. 3.53 3.24 2.85 2.45
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 3.53 3.24 2.85 2.45
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 3.53 3.24 2.85 2.45
Basic Normalized Net Income/Share 3.53 3.24 2.85 2.45
EPS fr Continuing Ops. 3.48 3.17 2.78 2.37
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 3.48 3.17 2.78 2.37
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 3.48 3.17 2.78 2.37
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
3.48 3.17 2.78 2.37
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with IDXX

Latest IDXX Headlines from TheStreet

More Financial News for IDXX

Press Releases for IDXX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter